TriSalus Life Sciences
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $12,878 | $11,407 | $8,899 | $13,205 |
Gross Profit | 11,095 | 9,899 | 7,669 | 11,443 |
EBITDA | -7,161 | -7,422 | 3,114 | -8,175 |
EBIT | -7,290 | -7,693 | 2,979 | -8,301 |
Net Income | -8,854 | -9,187 | 1,539 | -9,753 |
Net Change In Cash | 12,878 | 11,407 | 8,899 | 13,205 |
Free Cash Flow | -5,365 | -16,832 | -6,621 | -2,525 |
Cash | 41,057 | 46,288 | 56,553 | 20,439 |
Basic Shares | 61,659 | 58,296 | 52,314 | 46,844 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $45,151 | $29,431 | $18,511 | $12,398 |
Gross Profit | 38,186 | 25,328 | 15,906 | 10,140 |
EBITDA | -33,050 | -32,385 | -58,654 | -46,779 |
EBIT | -33,676 | -33,129 | -59,338 | -47,177 |
Net Income | -39,227 | -33,233 | -59,363 | -47,187 |
Net Change In Cash | 45,151 | 29,431 | 18,511 | 12,398 |
Free Cash Flow | -18,930 | -41,188 | -51,166 | -33,099 |
Cash | 20,439 | 8,525 | 11,777 | 9,414 |
Basic Shares | 37,897 | 26,501 | 26,465 | 29,608 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.15 |
2026-06-30 | -$0.16 |
2026-03-31 | $0.02 |
2025-12-31 | -$0.05 |